drugset / Trial / NCT06567002

A Study of MK-6552 and the Effect of Food in Healthy Participants (MK-6552-006)

NCT06567002

Phase 1 Terminated 24 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The primary purpose of this study is to learn what happens to levels of MK-6552 in the blood when MK-6552 is given in different forms to healthy adult participants under fasted and fed conditions.

Timeline

Start
2024-09-09
Primary completion
2024-11-15
Completion
2024-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-6552 Unknown Oral

Indications

No indication recorded.